Lewis H. Bender - 26 Mar 2026 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Reporting relationship: President and CEO, Director
Issuer ticker: INTS
Reported as of: 26 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Mar 2026, 17:29:06 UTC
Prior SEC filing: 06 May 2025
Next SEC filing: 20 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Kostantinos Skordalos, Attorney-in-fact

Key filing fact

Lewis H. Bender filed Form 4 for INTENSITY THERAPEUTICS, INC. (INTS) on 30 Mar 2026.

Key facts

This page summarizes Lewis H. Bender's Form 4 filing for INTENSITY THERAPEUTICS, INC. (INTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Mar 2026, 17:29.

Change

Previous filing in this sequence was filed on 06 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238705 Primary reporting owner

BENDER LEWIS H

Relationship: President and CEO, Director
Address: C/O INTENSITY THERAPEUTICS, INC., 1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Signature: /s/ Kostantinos Skordalos, Attorney-in-fact
Signature date: 30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INTS transaction

Common Stock, $0.0001 Par Value

Award

Transaction value
Shares: +37,749
Change %: +47%
Price: $6.11^*
Shares after: 118,549
Date: 26 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Granted to the Reporting Person as a fully vested stock award under the Issuer's 2021 Stock Incentive Plan in partial satisfaction of the 2025 bonus payment to the Reporting Person in lieu of cash, at the Reporting Person's request.

Footnote F2

On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.